Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Safety of Energy Drinks
NCT07212803Phase 4Recruiting
- Sponsor
- University of the Pacific
- Start
- Nov 2025
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (8 arms), sponsored by University of the Pacific. Primary endpoint: Corrected QT Interval. Started Nov 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07212803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07212803.